Tauopathies
📧 Sign up to get email alerts when something new happens for Tauopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation [Phase 2]
Phase 2 trial results for XPro1595 in early Alzheimer's disease with inflammatory biomarkers have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Validation of Blood Biomarkers for Alzheimer's Disease [NA]
A completed clinical trial from University Hospital, Montpellier validating blood biomarkers for Alzheimer's disease and related cognitive d…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15 [EARLY_Phase 1]
This EARLY Phase 1 study at the University of Pennsylvania is evaluating the biodistribution, metabolism, excretion, and brain uptake of the…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects [Phase 1]
Phase 1 randomized, double-blind, placebo-controlled, single ascending dose study of intravenously administered BMS-986168 in healthy subjec…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
This clinical trial update reports the long-term safety and efficacy follow-up of subjects who completed the Phase I study of Neurostem-AD.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.